<DOC>
	<DOC>NCT02632929</DOC>
	<brief_summary>The purpose of this study is to see whether the use of AMNIOEXCEL® improves healing and reduces the need to cut off all or part of a leg (amputation) in high-risk patients who have diabetes and foot sores (also sometimes called ulcers or wounds).</brief_summary>
	<brief_title>Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue</brief_title>
	<detailed_description>The purpose of this study is to demonstrate the effectiveness of comprehensive, interdisciplinary approach (usual care) in combination with early application of advanced therapy; dehydrated human amniotic membrane allografts (AMNIOEXCEL®, Derma Science, Princeton, New Jersey) in healing and preventing amputation in high risk patients with diabetic foot ulcers.</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Type 1 or 2 diabetes Ulcer anywhere on the foot Moderate to high risk for amputation according to Prevention of Amputation for Veterans Everywhere (PAVE) and the Society for Vascular Surgery Lower Extremity Threatened Limb (SVS WIfI) classification system (WIFi) criteria Inability or unwillingness to travel to Boise VA for clinic visits Enrolled in Hospice Have known or expected malignancy of foot ulcer Are or planning to become pregnant Signs of progressive gangrene, limbthreatening infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>foot ulcer, diabetic</keyword>
	<keyword>wound healing</keyword>
	<keyword>diabetic foot ulcer</keyword>
</DOC>